AWH Aspira Women's Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AWH

Price (delayed)

$3.21

Market cap

$33.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.49

Enterprise value

$30.16M

Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.

Highlights
The EPS has grown by 46% YoY and by 17% from the previous quarter
The net income has grown by 39% year-on-year and by 13% since the previous quarter
The company's quick ratio has shrunk by 55% YoY but it rose by 18% QoQ
The company's equity has shrunk by 106% YoY and by 25% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://aspirawh.com
Peers: RNR MHLD TRV

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
10.34M
Market cap
$33.18M
Enterprise value
$30.16M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.29
Earnings
Revenue
$9.18M
EBIT
-$20.97M
EBITDA
-$20.74M
Free cash flow
-$18.49M
Per share
EPS
-$2.49
Free cash flow per share
-$1.89
Book value per share
-$0.06
Revenue per share
$0.94
TBVPS
$0.89
Balance sheet
Total assets
$8.66M
Total liabilities
$9.32M
Debt
$2.34M
Equity
-$659,000
Working capital
$2.41M
Liquidity
Debt to equity
-3.55
Current ratio
1.47
Quick ratio
1.35
Net debt/EBITDA
0.15
Margins
EBITDA margin
-226%
Gross margin
57.6%
Net margin
-227.8%
Operating margin
-198.1%
Efficiency
Return on assets
-184.8%
Return on equity
-1,263.4%
Return on invested capital
-2,059.6%
Return on capital employed
-599.1%
Return on sales
-228.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
0%
1 week
0.94%
1 month
-30.22%
1 year
-95.68%
YTD
-95.71%
QTD
-40.11%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$9.18M
Gross profit
$5.29M
Operating income
-$18.18M
Net income
-$20.91M
Gross margin
57.6%
Net margin
-227.8%
Aspira Women's Health's operating margin has soared by 55% YoY and by 21% from the previous quarter
The operating income has grown by 48% year-on-year and by 20% since the previous quarter
The net margin has increased by 48% year-on-year and by 14% since the previous quarter
The net income has grown by 39% year-on-year and by 13% since the previous quarter

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
3.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.29
The EPS has grown by 46% YoY and by 17% from the previous quarter
The company's equity has shrunk by 106% YoY and by 25% QoQ
AWH's price to sales (P/S) is 91% less than its 5-year quarterly average of 39.2 and 27% less than its last 4 quarters average of 4.7
Aspira Women's Health's revenue has increased by 16% YoY

Efficiency

How efficient is Aspira Women's Health business performance
The ROE has plunged by 143% from the previous quarter
The ROA has plunged by 62% YoY and by 17% from the previous quarter
The ROS has grown by 47% YoY and by 14% from the previous quarter
Aspira Women's Health's ROIC has increased by 45% from the previous quarter

Dividends

What is AWH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 7% less than its total liabilities
Aspira Women's Health's total assets has plunged by 64% YoY but it has increased by 12% from the previous quarter
The company's quick ratio has shrunk by 55% YoY but it rose by 18% QoQ
The company's equity has shrunk by 106% YoY and by 25% QoQ
The debt has declined by 25% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.